Biomarkers for personalizing and precision IBD therapies

Artificial intelligence in prognosis and precision medicine for inflammatory bowel disease

Nanomedicine-mediated drug delivery for potential treatment of inflammatory bowel disease

Autotaxin induces S1P/S1PR1 signaling to affect Th17/Treg cell balance and exacerbate intestinal inflammation in colitis

Machine learning models for predicting ustekinumab response in Crohn's disease patients based on pathological features

How to choose a second biologic agent for Crohn’s disease: the state of the art

Is there a superior first line biological/small molecule in CD: positioning advanced therapy in the treatment of CD

Treatment of perianal fistulizing crohn's diseae: emerging evidence and clinical application

Speed of early symptomatic remission with advanced biological therapies for moderate-to-severe ulcerative colitis

Current evidence for combined targeted therapy for the treatment of IBD and EIM

An eye on eye: when and how to rescue ocular manifestations of inflammatory bowel disease

Arthropathic manifestations of inflammatory bowel disease: potential therapeutic approaches

Inflammatory bowel disease and primary sclerosing cholangitis: emerging therapy according to dominant behavior

Research progress on dietary factors, intestinal flora and the pathogenesis of inflammatory bowel disease

Prevalence of and factors associated with extraintestinal manifestations induced by biologics

Challenge case I

Challenge case II

Challenge case III

Challenge case IV

Challenge case V

Challenge case VI